Frankfurt - Delayed Quote EUR

Sanofi (SNW2.F)

46.60
0.00
(0.00%)
At close: May 21 at 3:50:31 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 9.89B
Earnings 2.21B

Q2'24

Q3'24

Q4'24

Q1'25

0
5B
10B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in EUR Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 551515
Avg. Estimate 9.99B12.97B45.22B48.27B
Low Estimate 9.73B12.71B43.4B45.75B
High Estimate 10.24B13.2B48.23B51.39B
Year Ago Sales 10.74B13.44B41.08B45.22B
Sales Growth (year/est) -7.00%-3.47%10.08%6.73%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SNW2.F --------
S&P 500 13.32%2.61%7.73%13.77%

Upgrades & Downgrades

Initiated Goldman Sachs: Neutral 3/21/2025
Maintains Argus Research: Buy to Buy 7/26/2024
Initiated Morgan Stanley: Equal-Weight 1/23/2024
Maintains Argus Research: Buy 3/27/2023
Upgrade Deutsche Bank: Sell to Hold 8/12/2022
Upgrade SVB Leerink: Market Perform to Outperform 9/27/2021

Related Tickers